Abstract
A higher incidence of multiple psychiatric disorders occurs in people born in late winter/early spring. Reduced light exposure/activity level impacts adult rodent behavior and neural mechanisms, yet few studies have investigated such light exposure on gestating fetuses. A dysfunctional dopamine system is implicated in most psychiatric disorders, and genetic polymorphisms reducing expression of the dopamine transporter (DAT) are associated with some conditions. Furthermore, adult mice with reduced DAT expression (DAT-HT) were hypersensitive to short active (SA; 19:5 L:D) photoperiod exposure versus their wildtype (WT) littermates. Effects of SA photoperiod exposure during gestation in these mice have not been examined. We confirmed adult females exhibit a heightened corticosterone response when in SA photoperiod. We then tested DAT-HT mice and WT littermates in psychiatry-relevant behavioral tests after SA or normal active (NA; 12:12 L:D) photoperiod exposure during gestation and early life. SA-born WT mice exhibited sensorimotor gating deficits (males), increased reward preference, less immobility, open arm avoidance (females), less motivation to obtain a reward, and reversal learning deficits, vs. NA-born WT mice. DAT-HT mice were largely resilient to these effects, however. Future studies will determine the mechanism(s) by which SA photoperiod exposure influences brain development to predispose toward emergence of psychiatry-relevant behaviors.
Subject terms: Neuroscience, Diseases
Introduction
A higher incidence of multiple psychiatric disorders, including major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SZ), occurs in people born in late winter/early spring1,2. Some factors arising from a winter gestation have been investigated to determine whether they drive outcomes that are relevant to psychiatric disorders, including maternal vitamin D deficiency and malnutrition (reviewed by Cope et al., 2016)3. To-date, little investigation has been made of reduced light exposure/activity levels, despite evidence they can impact adult behavior and neural mechanisms in rats and mice (see below). Altered light exposure during the perinatal period also induces lasting changes in the circadian clock of rodent offspring4. Relatively little investigation into the behavioral effects of altered perinatal photoperiod exposure has been conducted in such rodent offspring, although reduced immobility in the forced swim test (FST) has been reported (see Green et al., 2015)5. The question therefore remains as to what effect altered perinatal photoperiod exposure has on psychiatry-relevant behaviors in adults, that is behaviors observed in clinical psychiatric populations that can be observed in rodent models using cross-species translational tasks6–13.
In adult rodents, exposure to short active (SA; winter-like; 19:5 light:dark (L:D)) photoperiod increased stress-related hormones as well as psychiatry-relevant behavioral changes14. Specifically, after 7 days in a SA photoperiod, rats exhibited reduced time spent in the open arms of the elevated plus maze (EPM) and increased immobility in the FST, consistent with an anxiogenic- and depression-like profile. This profile coincided with neurotransmitter respecification occurring in the paraventricular nucleus of the hypothalamus which in a standard condition expressed tyrosine hydroxylase (TH), somatostatin (SST), and corticotropin-releasing factor (CRF), but in a SA condition expressed less TH, and more SST and CRF. A 14-day SA photoperiod exposure induced similar behavioral and neurotransmitter changes in mice, effects that were exaggerated in mice with reduced dopamine transporter (DAT) expression15. The effects of this stress-related response to winter-like-induced inactivity on gestation, however, have yet to be investigated.
While environmental factors such as winter gestation contribute to the development of psychiatric illnesses, genetic factors also play a role16. Many psychiatric disorders result from a complex interplay between environmental risk factors and an individual’s genetic background risk17–20, making the identification of genetic susceptibility/resiliency factors critical to understanding psychiatric disorder pathogenesis. Case-control, family cohort, and GWAS studies have repeatedly linked polymorphisms in SLC6A3, the gene encoding DAT, to multiple psychiatric conditions21–36. Polymorphisms in DAT—the main homeostatic mechanism for synaptic DA clearance—are associated with BD23,35,37,38, SZ25–28, and ADHD21,22,29–32,39. Reduced DAT levels (~40%) were observed in euthymic BD patients, and reduced DAT expression was confirmed in postmortem frontal cortices of BD patients40. Furthermore, DAT polymorphisms associated with psychiatric disease risk differentially modulate DAT gene promoter activity41,42. A subset of studies have not found an association between DAT and these disorders43–46; although a large number of studies support this association (above), and none determine potential interactive effects of season of birth. Such polymorphisms have been associated with reduced DAT expression and as indicated above, reduced DAT expression in mice induced a hypersensitivity to SA-photoperiod effects in adulthood15. Given that SA-photoperiod reduces levels of the precursor to dopamine, tyrosine hydroxylase14,15 there may be an interaction between genetic factors influencing DAT expression levels and photoperiod exposure on behavioral outcomes. Hence, reduced DAT expression could confer a similar sensitivity to photoperiod-induced behaviors during gestation and needs to be investigated.
To determine the effects of altered perinatal photoperiod on behavioral profiles in adulthood, we bred and raised mice in a SA vs. normal active (NA; 12:12 L:D) photoperiod. Additionally, we determined whether mice heterozygous for a DAT mutation that reduces DAT expression (DAT-HT) demonstrated an increased susceptibility to photoperiod-induced behavioral effects. We hypothesized that: 1) mice born/raised in SA photoperiod would exhibit psychiatry-relevant behavior vs. NA-born mice; and 2) DAT-HT mice would be hypersensitive to SA-induced behavioral changes compared to WT mice.
Methods
Dopamine transporter knockdown (DAT KD) line
A 7.5-kb HindIII fragment with the first two DAT gene exons was excised from a phage DNA isolated from a mouse 129 Sv/J genomic library, and a NotI—AscI cassette was inserted to generate the targeting construct. The insertion of an extra 4-kb DNA sequence (tTA-neo-tetO) reduced DAT expression levels. W9.5 embryonic stem cells were electroporated with the linearized targeting construct and injected into C57BL6/J blastocysts to generate chimeras. One chimera was mated with 129 Sv/J females to generate heterozygous mutants (DAT-HT) on a 129 Sv/J background47. DAT-HT breeding pairs were sent to our laboratory from Columbia University and all subsequent mice resulted from a breeding colony in the vivarium at the University of California, San Diego (UCSD). Mice were bred until the DAT mutation was crossed over to a C57BL6/J background (>10 generations of backcrossing) and then maintained on this background. DAT-HT mice express ~50% of DAT compared to wildtype (WT) levels15.
Animals for current experiments
Male (20–30 g) and female (15–25 g) DAT-HT and WT littermates were generated from DAT-HT (sire)/C57BL/6J (dam) pairings after being placed in custom photoperiod chambers (see Photoperiod Exposure Paradigm section below). Behavioral testing began at approximately 10 weeks old (see Fig. 1b for timeline). When not in the photoperiod chambers, all mice were group housed (3–4/cage) and were maintained on a reversed day-night light cycle (lights on 7:00 pm, off at 7:00 am) in a temperature-controlled vivarium. All behavioral tests occurred during the active (dark) phase of the cycle. Food and water were provided ad libitum. All procedures and tests were approved by the UCSD Institutional Animal Care and Use Committee. The UCSD animal vivarium meets all federal and state requirements for animal care and was approved by the American Association for Accreditation of Laboratory Animal Care.
Plasma corticosterone assay
For confirmation of a SA-photoperiod stress-induced response at a hormonal level, adult female C57BL6/J mice were exposed to NA or SA photoperiod for 14 days, after which tail blood was collected for baseline plasma corticosterone (CORT) assessment. On day 15, tail blood was collected after a 2-hour acute restraint stress. Blood samples were analyzed for plasma CORT using a corticosterone rat/mouse ELISA kit (Rocky Mountain Diagnostics, Inc., Colorado Springs, CO, USA). A ratio of day 15 to day 14 plasma CORT levels was used for analyses.
Photoperiod exposure paradigm
Male DAT-HT and female C57BL/6J breeders were placed into custom photoperiod chambers programmed to a NA (12:12 L:D) cycle prior to pairing in order to acclimate to the chambers (6 cages per chamber). Ten photoperiod chambers are individually ventilated and illuminated to 130 lumens (measured in the center of the chamber) by three horizontal, programmable white LED strips equally spaced on each wall. After a 7-day acclimation period, breeding triads (2 female: 1 male) were formed; half the breeding pairs remained in NA photoperiod, while half the breeding pairs were switched to SA photoperiod (19:5 L:D). Following a two-week pairing, dams were singly housed and maintained in their respective photoperiods (NA or SA) throughout pregnancy. The resulting 238 pups remained in either NA or SA photoperiod until weaning at P28. This photoperiod exposure was chosen to recreate the time period exposure of earlier research in this area5, as well as our work in adult photoperiod exposure inducing a stress-relevant response14,15,48. This time period was further supported given that neurodevelopmental timelines between mice and humans indicate that milestones in humans (e.g., peak brain growth spurts, 36–40 weeks) occur in mice post birth (postnatal days 7–10)49. Although not recreating the gradual change that occurs during human gestation, these conditions determine whether extreme photoperiod changes drive altered behavioral profiles in offspring. At P28, all pups were weaned by sex and genotype, moved into a standard vivarium room, and housed in NA photoperiod (12:12 L:D). For all subsequent behavioral testing, mice were maintained in NA photoperiod (see Fig. 1 for a schematic of experimental housing and testing timelines).
Behavioral testing
To examine psychiatry-relevant behaviors induced by gestation/rearing in SA photoperiod, we assessed several domains commonly altered in patients with psychiatric disorders. Each test was performed as described below. The entire cohort of mice (N = 238) was tested in the behavioral pattern monitor (BPM), prepulse inhibition (PPI), and saccharin preference (SP) tests, whereas only half the cohort was used (n = 121) for the forced swim test (FST) and elevated plus maze (EPM). We used half the cohort for the latter two tests to minimize re-testing effects for other experiments (experiments not included here). An 8.5-week period elapsed between FST and EPM testing to minimize FST effects on EPM behavior (Fig. 1b). 16 weeks after EPM testing, a subset of these mice (n = 74; 8–10 per group) were trained in the progressive ratio breakpoint task (PRBT) and Probabilistic Reversal Learning Task (PRLT). See “Operant Training Phases” section below for details, and Fig. 1b for timeline of operant training and testing.
Prepulse inhibition (PPI): sensorimotor gating
Startle and PPI was tested using eight startle chambers (SR-LAB, San Diego Instruments, USA), each consisting of a Plexiglas cylinder (5 cm diameter) resting on a platform in a ventilated sound-attenuating box. Speakers located 33 cm above the cylinders produced all acoustic stimuli. Animal movements were transduced by piezoelectric accelerometers located underneath each cylinder, and data was stored and digitized by an interface and computer assembly. Mice were placed into startle chambers and underwent a 5-minute acclimation period prior to testing. Mice were exposed to a 65 dB background sound, as well as a light located on the chamber ceiling, continuously throughout the session.
Startle pulse duration was 40 ms, and prepulses were 20 ms in duration. The inter-trial interval (ITI) was on average 7 seconds (range: 3–12 s). The inter-stimulus interval (ISI) for prepulse trials was 100 ms (except for varying ISI trials below). Each session consisted of six blocks: (1) five 120 dB pulses, (2) prepulses (69, 73, 81 dB) preceding 100 dB pulses, (3) prepulses (69, 73, 81 dB) preceding 120 dB pulses, (4) varying ISI trials (73 dB prepulses preceding 120 dB pulses by 25, 50, 100, 200, and 500 ms, (5) startle trials (69, 73, 80, 90, 100, 110, 120 dB pulses), and (6) five 120 dB pulses. Startle responses to the 120 dB pulses from the first and sixth blocks were used to assess habituation across the session. PPI was calculated as a percentage for both the 100 dB and 120 dB pulses: %PPI = 100 – [(startle magnitude for prepulse+pulse/startle magnitude for pulse alone) × 100].
Behavioral pattern monitor (BPM): locomotor activity, exploratory behavior
Mice were tested in eight BPM chambers, each consisting of a 30.5 × 60 × 38 cm arena. Infrared beams designed to detect horizontal activity (e.g. number of transitions from one predefined region of the arena to another), vertical activity (e.g. rearing), and holepokes, tracked behavior across the 45-minute session. Behavioral data was acquired using Photobeam Activity System software (San Diego Instruments, USA). Custom programming was used to convert data into a format that could be analyzed using Biomedical Data Programs software (Statistical Solutions Inc., Saugus, MA). Detailed information regarding the chambers and testing methods have been previously published50–53. Mice were placed in the upper left corner of the chamber at the beginning of the session and could freely explore the arena. Primary outcomes included number of transitions, rearing, holepokes, and spatial d (a value quantifying the geometrical pattern of locomotor activity across the session, whereby values near 1 reflect straight line paths, values closer to 2 reflect a circumscribed path, and values near 1.5 reflect a meandering path). These measures were chosen given the difference between people with BD mania, acute schizophrenia episode, and healthy participants, and the ability to recreate such altered profiles in mouse models7,54.
Saccharin preference test (SPT): reward preference, hedonia-like behavior
Mice had 72-hour unrestricted access to both a normal water bottle and a water bottle filled with 1% saccharin solution in their home cage (3–4 mice/cage). Both bottles were weighed three times (once/day) by experimenters, and percent saccharin preference/cage was calculated as the primary outcome. All cage values were averaged within each group and compared to the other group averages.
Forced swim test (FST): despair-related behavior
Animals were placed into a 4.0L beaker filled with 2.5L of room temperature water. Animals were unable to touch the bottom of the beaker. The beaker was enclosed on all sides by a black box, and the experimenter observed behavior by video camera. The primary outcome variable, time spent immobile (seconds), was manually scored using ODLog software (Macropod Software) over the 5-minute session by people unblinded. Mice were judged “immobile” when not actively swimming. The first minute of data was subtracted to prevent obfuscation of perinatal photoperiod effects, as mice tend to be more active during the first portion of this test55.
Elevated plus maze (EPM): “anxiety-like” behavior, risk preference
Mice were placed in the center of the EPM at the beginning of the session. The EPM consisted of two open arms, two closed arms (Plexiglass walls covered with black paper), and an exposed center area. Mice could freely explore the maze for the entirety of the 5-minute session. Time spent in each open and closed arm, as well as in the center, was manually tracked using ODLog Software (Macropod Software). Primary outcomes included percent time spent in the open arms, percent time spent in the closed arms, and percent time spent in the center.
Operant training phases
Mice were initially trained in five-hole operant chambers (25 × 25 × 25 cm; Med Associates, St. Albans, USA). One week prior to initiation of Hab1 training, mice were food deprived to 85% of free-feeding body weight. During the first training phase (Hab1; 1 session/day), mice were conditioned to associate magazine illumination with the opportunity to collect 30 μl strawberry milkshake from the magazine. In the second training phase (Hab2; 1 session/day), mice were required to nose poke in any of the five illuminated holes to receive the reward (criterion: at least 70 responses for two consecutive days during 30-minute session). Once criterion was reached, mice moved into the testing phase.
Progressive ratio breakpoint task (PRBT): motivation to obtain reward
During a 60 min PRBT (tested on one day), mice had to make increasingly more holepokes into the central lit port in order to get a milkshake reward. The number of holepokes required to receive the reward increased in the following progression: 1, 2, 4, 7, 11, 16, 22, 29, 37, 46, 56, and 67 (see56,57). Mice had to respond three times at each ratio before moving on to the next ratio. If mice did not nose poke within 10 seconds, the chamber house light was illuminated for 4 seconds with all holes being inoperative until the next trial initiated. Primary outcome measure was breakpoint, defined as the last ratio completed before the end of the session. Secondary outcomes included total trials completed, mean reaction time, mean trial completion time, and mean response rate.
Probabilistic reversal learning task (PRLT): reversal learning
During a 60 min PRLT (tested on one day), mice were presented with two lit ports associated with different contingencies: the target port was associated with a high probability of reward (80%) and low probability of punishment (20%). The non-target port was associated with a low probability of reward (20%) and high probability of punishment (80%). After 8 consecutive responses in the target port, criterion was met, and the target port became the non-target port and vice versa (reversal). If mice did not nose poke within 10 seconds, the chamber house light was illuminated for 4 seconds with all holes being inoperative until the next trial initiated. Primary outcome measure was number of reversals completed in the 60 min session. Secondary outcomes analyzed for this task have been previously published by our lab57.
Operant training phase, PRBT, and PRLT data collection
Recording of responses in the operant training phases, as well as for PRBT and PRLT, was managed by a SmartCtrl Package 8-In/16-Out with additional interfacing by MED-PC for Windows (Med Associates, St. Albans, USA) using custom programming. Data was imported into Microsoft Excel using MED-PC to Excel (Med Associates, St. Albans, USA), and subsequently used for analysis.
Statistical analyses
Primary outcomes from behavioral experiments were analyzed using ANOVA, with between-subjects factors of sex, genotype, and perinatal photoperiod exposure. Analyses were collapsed across sex where no main or interactive effect of sex was observed. For SPT, a within-subjects factor of time was included to assess differences in saccharin preference across the 3-day test period. For PPI, intra-block PPI measures (varying pulse intensities, ISI, or habituation), were added to the analysis as within-subjects factors. BPM data was analyzed across the entire 45-minute test session, as well as in 15-minute time bins (as a within-subjects factor). For the plasma corticosterone study, an unpaired t-test was used to assess for photoperiod effects on CORT levels. Data was analyzed using SPSS 24.0 (IBM Corp., Armonk, NY), except for BPM data, which was analyzed using Biomedical Data Programs software (Statistical Solutions Inc., Saugus, MA).
Results
SA-photoperiod effects on adult female plasma corticosterone levels
To determine whether the SA photoperiod drove a stress response in female mice, and hence had the potential to affect offspring, adult female mice were exposed to either NA or SA photoperiod for 14 days. Following this photoperiod exposure, SA-exposed adult female mice exhibited higher acute stress/baseline plasma corticosterone (CORT) ratios compared to NA-exposed females after a 2-hour acute restraint stress (t(21) = 2.6, p < 0.05; Fig. 1c).
Sensorimotor gating and startle: Prepulse inhibition (PPI)
Interactions with perinatal photoperiod were observed at both 100 dB and 120 dB. At 100 dB, a prepulse intensity x sex x genotype x perinatal photoperiod interaction was observed (F(1.9,440) = 4.9, p < 0.01). Sex-specific analysis showed a prepulse intensity x genotype x perinatal photoperiod interaction in males, but not in females (males: F(2,256) = 4.7, p < 0.05; females: F(2,204) = 1.4, ns; Fig. 2a,b). Further restriction by genotype in males showed a prepulse intensity x perinatal photoperiod interaction in WT mice (F(2,128) = 4.0, p < 0.05), with SA-born WT mice exhibiting reduced PPI compared to NA-born WT mice at the 73 dB prepulse level (p < 0.01). A main effect of photoperiod was also observed in male WT mice, with SA-born male WT mice exhibiting deficient PPI compared to NA-born male WT mice (F(1,64) = 5.5, p < 0.05). There were no interactions with perinatal photoperiod observed in male DAT-HT mice; additionally, no main effect of perinatal photoperiod was observed (F(1,64) = 2.9, ns). There was a main effect of genotype in female mice (F(1,102) = 9.4, p < 0.01), with female DAT-HT mice exhibiting deficient PPI compared to female WT littermates. No significant interactions were seen in the pulse intensity or habituation curves at 100 dB.
At 120 dB, a sex x perinatal photoperiod interaction was observed (F(1,230) = 9.8, p < 0.01). Sex-specific analysis showed a main effect of perinatal photoperiod in males only (F(1,128) = 9.3, p < 0.01; Fig. 2c), with SA-born males exhibiting reduced PPI compared to NA-born males. At each prepulse intensity, SA-born male WT mice exhibited deficient PPI compared to NA-born male WT littermates; this difference was only significant at the highest prepulse intensity in SA-born vs. NA-born male DAT-HT mice. No interactions or main effects were observed in female mice, except for a main effect of prepulse intensity (Fig. 2d). No sex x perinatal photoperiod interactions were observed in the pulse intensity or habituation curves at 120 dB.
Exploratory behavior: Behavioral pattern monitor (BPM)
When data were analyzed in a single 45-minute time bin, no interactions with or main effects of perinatal photoperiod were observed in any BPM primary outcome measures (number of transitions, rearing, holepokes, or spatial d). A main effect of genotype was observed for number of transitions (F(1,230) = 13.9, p < 0.001; Fig. 3a), rearing (F(1,230) = 28.0, p < 0.0001; Fig. 3b), and spatial d (F(1,230) = 5.1, p < 0.05; Fig. 3c). DAT-HT mice exhibited increases in number of transitions and rearings, as well as a reduction in spatial d, compared to WT littermates.
When data were analyzed in 15-minute time bins, a time x genotype x perinatal photoperiod interaction was observed for holepokes (F(2,460) = 3.1, p < 0.05; Fig. 3d). All groups, regardless of genotype or perinatal photoperiod exposure, exhibited a significant increase in holepokes between the first and second 15-minute time bin (NA-born WT: t(112) = 2.4, p < 0.05; NA-born DAT-HT: t(116) = 4.0, p < 0.01; SA-born WT: t(134) = 2.7, p < 0.01; SA-born DAT-HT: t(104) = 2.9, p < 0.01). When examining for inter-group differences at each time point, no significant differences were observed during the first or second 15-minute time bin. During the final 15-minute time bin, NA-born DAT-HT mice completed significantly more holepokes compared to NA-born WT mice (t(114) = 2.3, p < 0.05).
A time x perinatal photoperiod interaction for spatial d was observed when data were analyzed in 15-minute time bins (F(2,240) = 5.3, p < 0.01; Fig. 3e). Both NA-born and SA-born mice exhibited an increased spatial d between the first and second 15-minute time bin (NA: t(230) = 3.9, p < 0.01; SA: t(240) = 4.2, p < 0.0001). A further increase in spatial d was observed between the second and third 15-minute time bin in NA-born mice (t(230) = 2.3, p < 0.05); this effect was not observed in SA-born mice (t(240) = 0.8).
Reward sensitivity: Saccharin preference test (SPT)
When tested as adults, mice born and raised in SA photoperiod tended to exhibit increased saccharin preference when compared to NA-born mice (F(1,51) = 3.2, p = 0.08). No interactions with sex or genotype were observed in the overall analysis. Given our a priori hypothesis of genotype-specific effects, we performed genotype-specific analyses of SP. SA-born WT mice exhibited increased saccharin preference compared to NA-born WT mice (F(1,26) = 7.8, p < 0.05; Fig. 4a), whereas there were no photoperiod effects in DAT-HT mice (F(1,25) = 0.0, ns; Fig. 4a).
Behavioral despair: Forced swim test (FST)
When tested as adults, mice born and reared in SA photoperiod exhibited a trend toward decreased immobility in the FST, regardless of genotype, when compared to NA-born mice (F(1,113) = 3.8, p = 0.06). A main effect of sex was also observed, with males spending more time immobile compared to females (F(1,113) = 16.7, p < 0.001). Given our a priori hypothesis that these effects would be genotype-specific, we investigated photoperiod effects in each genotype. In WT mice, there was a main effect of photoperiod (F(1,61) = 5.2, p < 0.05; Fig. 4b), where SA-born WT mice exhibited decreased immobility compared to NA-born WT mice. In contrast, no photoperiod effect was observed in DAT-HT mice (F(1,52) = 0.4, ns; Fig. 4b).
Risk preference/anxiety assessment: Elevated plus maze (EPM)
A sex x genotype x perinatal photoperiod interaction for percent time spent in open arms was observed in the EPM (F(1,112) = 6.0, p < 0.05). When males and females were analyzed separately, no interactions with or main effects of perinatal photoperiod were observed. In females only, a trend toward a genotype x perinatal photoperiod interaction was observed (F(1,51) = 3.7, p = 0.06). Female SA-born WT mice spent significantly less time in open arms compared to female NA-born WT mice (t(29) = 2.1, p < 0.05; Fig. 4c). SA-born female DAT-HT mice spent significantly more time in open arms compared to SA-born female WT mice (t(26) = 2.9, p < 0.01; Fig. 4c). A main effect of genotype was also seen in female mice, with DAT-HT mice spending more time in open arms compared to WT mice (F(1,51) = 6.5, p < 0.05). In male mice, SA-born DAT-HT mice spent less time in open arms compared to SA-born WT mice (F(1,36) = 6.9, p < 0.05; Fig. 4c).
Effort valuation: Progressive ratio breakpoint task (PRBT)
During Hab2 training, there was a sex x genotype x perinatal photoperiod interaction (F(1,66) = 5.9, p < 0.05). SA-born male WT mice took significantly more sessions to meet criterion than all other groups (p < 0.0001 vs. female DAT-HT NA; p < 0.001 vs. female WT NA, female WT SA, male DAT-HT SA; p < 0.01 vs. female DAT-HT SA, male WT NA, male DAT-HT NA). In the PRBT, a genotype x perinatal photoperiod interaction was observed for breakpoint (F(1,66) = 6.1, p < 0.05; Fig. 5a). SA-born WT mice exhibited a reduced breakpoint vs. NA-born WT mice (F(1,36) = 12.6, p < 0.01) as well as vs. SA-born DAT-HT mice (F(1,35) = 10.5, p < 0.01). Genotype x perinatal photoperiod interactions were also observed for most secondary outcome measures. SA-born WT mice completed fewer trials (F(1,66) = 5.3, p < 0.05; Fig. 5b), had slower reaction times (F(1,66) = 5.6, p < 0.05; Fig. 5c), took longer to complete each trial (F(1,66) = 5.5, p < 0.05; Fig. 5d), and exhibited increased mean response rates (F(1,66) = 6.1, p < 0.05; Fig. 5e) compared to all other groups. A main effect of perinatal photoperiod was also observed on mean reward latency, with SA-born mice taking longer to retrieve earned rewards than NA-born mice (F(1,66) = 13.8, p < 0.001; Fig. 5f).
Reversal learning: Probabilistic reversal learning task (PRLT)
A genotype x perinatal photoperiod interaction was observed for number of switches completed during the PRLT session (F(1,66) = 6.9, p < 0.05; Fig. 6a). SA-born WT mice completed fewer switches compared to NA-born WT mice (F(1,36) = 5.9, p < 0.05; Fig. 6a). NA-born DAT-HT mice completed fewer switches compared to NA-born WT mice (F(1,35) = 5.0, p < 0.05; Fig. 6a). For secondary outcome measures, a genotype x perinatal photoperiod interaction was observed for mean reward latency (F(1,66) = 7.6, p < 0.01; Fig. 6b) and target win-stay ratio (F(1,66) = 7.3, p < 0.01; Fig. 6c). Target win-stay ratio represents the probability of choosing the target port after being rewarded from choosing the target port in the previous trial. SA-born WT mice exhibited an increased latency to collect rewards after being rewarded compared to both NA-born WT mice (F(1,36) = 7.8, p < 0.01) and SA-born DAT-HT mice (F(1,35) = 7.4, p < 0.05). SA-born WT mice exhibited a reduced target win-stay ratio compared to NA-born WT mice (F(1,36) = 5.6, p < 0.05). NA-born DAT-HT mice also showed a reduced target win-stay ratio relative to NA-born WT mice (F(1,35) = 5.8, p < 0.05).
Discussion
Exposure to short active (SA; 19:5 L:D) photoperiod increased corticosterone levels in adult female mice. Exposure to this SA photoperiod during pregnancy and early life induced psychiatry-relevant behavioral profiles in WT mice. Specifically, SA-born WT mice exhibited reduced PPI (males only), increased saccharin preference, reduced FST immobility, less time spent in open arms of EPM (females only), less motivation to obtain a reward (breakpoint; PRBT), and reversal learning deficits (switches; PRLT), compared to NA-born WT mice (see Table 1 for summary of behavioral results). No SA photoperiod effects were observed in the BPM, suggesting perinatal SA photoperiod exposure does not alter locomotor activity or exploratory behavior. Surprisingly, mice with reduced DAT expression (DAT-HT mice) that were hypersensitive to SA photoperiod effects in adulthood15, were largely resistant to the effects of gestational SA photoperiod exposure (with the exception of significant PPI deficits observed at the highest prepulse level, 81 dB; Table 1). Thus, recreating a winter-like SA photoperiod exposure in mice during gestation resulted in psychiatry-relevant behavioral abnormalities in adulthood, for which mice with reduced DAT expression were resilient.
Table 1.
Behavior (Test) | Potential Relevance to Human Condition | Effect in WT (vs. NA-born WT) | Effect in DAT-HT (vs. NA-born DAT-HT) |
---|---|---|---|
Sensorimotor gating (PPI) | Deficits seen in patients with schizophrenia (SZ)58,59, obsessive-compulsive disorder (OCD)60,61, autism spectrium disorder (ASD) in children/ adolescents62 |
100 & 120 dB: ↓ PPI (males only) |
100 dB: no effect 120 dB: ↓ PPI (males only; 81 dB prepulse level only) |
Locomotor activity/ Exploration (BPM) | Hyperlocomotion, hyperexploration, and altered motor activity patterns seen in patients with mania51,97,98 | None | None |
Reward preference, Hedonia (SPT) | Used in rodent models as a measure of anhedonia65; anhedonia cardinal feature of major depressive disorder (MDD)64 | ↑ SP | None |
Despair-related behavior (FST) | Commonly used in rodent models as metric for depression-like behaviors seen in humans (e.g. despair)69,70 | ↓ immobility | None |
“Anxiety-like” behavior, risk preference (EPM) | Used in animal models to measure anxiety behavior seen in humans99,100 |
↓ time spent in open arms (females only) |
None |
Motivation to obtain reward (PRBT) | Decreased breakpoint in patients with SZ75,101, patients with MDD less willing to expend effort to obtain reward102 |
↓ breakpoint (less motivated) |
None |
Reversal learning (PRLT) | Impaired reversal learning in SZ76,78, OCD103 | ↓ reversal learning | None |
The behavioral tests in the current study were selected to span a broad array of psychiatry-relevant behaviors consistent with those observed in patient populations. PPI deficits (reflecting sensorimotor gating deficits) have been observed in patients with SZ58,59, obsessive-compulsive disorder (OCD)60,61, and children/adolescents with ASD62. Cortico-striato-pallidopontine (CSPP) circuitry regulates PPI, and has been implicated in the pathology of multiple psychiatric disorders63. SA perinatal photoperiod exposure may therefore influence CSPP circuitry (given the observed SA-induced PPI deficits), reflecting one way altered photoperiod exposure near birth might contribute to emergence of psychiatry-relevant behaviors in adulthood. Two of the tests included in this study (SPT, FST) are commonly used in animals to provide insight into depression-relevant behaviors. Given that anhedonia is a cardinal feature of MDD64, it is thought that the SPT measures such behavior in rodents65, despite unaltered SPT in people with depression relative to healthy participants66–68. Time spent immobile in the FST is a biological readout of altered behavior and has been associated with depression-relevant behaviors (e.g. behavioral despair)69,70. In both tests, SA-born WT mice exhibited the opposite of expectations of ‘anhedonic’-like profile, exhibiting increased saccharin preference and decreased FST immobility. While the relationship of these findings to aspects of depression remain unclear, the photoperiod gestation challenge affected behavior in these tests. The mechanism driving these effects remains unclear, but it is important to note that a similar photoperiod manipulation resulted in reduced FST immobility in a previous study5; this consistency across photoperiod studies (albeit with minor mouse background and 1 hour light change differences), from different laboratories supports the validity of these outcome measures. That study suggested the SA-born-induced reduction in immobility may have been as a result of a hyper-serotonergic dorsal raphe nuclei, but the dopaminergic system may also play a role in this effect given that mice with reduced DAT expression were resistant to this SA-born effect.
Although FST immobility has commonly been used as a metric for depression-relevant behaviors (e.g. despair), this interpretation may not accurately reflect what the behavior represents. Some suggest immobility is an adaptive learned response and reflects a coping strategy to the FST stressor71. Others argue that reduced immobility may represent an anxiogenic behavioral profile, rather than an ‘antidepressant’ effect72. Therefore, the reduced immobility seen in SA-born mice could be an anxiogenic state or a maladaptive response to stress. An anxiogenic state is further supported by SA-born WT mice (females) spending less time in the open arms of the EPM. However, it is important to note that prior FST exposure has been shown to induce an anxiogenic behavioral profile in the EPM (in male mice)73. As a result, we cannot rule out the possibility that FST testing influenced EPM results. Reduced breakpoint (PRBT) and impaired probabilistic learning (PRLT) are outcomes viewed as more proximate to amotivated behavior in SZ74–76 and depression77. Furthermore, these tests are more translationally relevant, as versions of these tasks have been implemented in both rodents and human populations. Reduced breakpoint from a PRBT predicts 24% of the variance of global cognitive functioning in patients with SZ, with lower breakpoints associated with greater severity of certain negative symptoms (anhedonia, avolition)75. Impaired PRLT has also been observed in patients with SZ78. Given that FST immobility more than likely does not serve as an accurate measure of motivated behavior, the decreased FST immobility and reduced breakpoint observed in SA-born mice in the current study are not necessarily contradictory. That slowed latencies to collect rewards were observed in SA-born WT mice in both the PRBT and PRLT indicate a reduced motivation to exert effort to collect rewards. The lack of difference of overall activity levels in an exploratory chamber (BPM), suggests this amotivated behavior is specific to the collection of reward. Given the reduced win-stay behavior of SA-born WT mice, these deficits may also arise from impaired reward processing. Future studies examining effort-related choice will likely be useful in determining the impact of this manipulation on motivated behaviors.
Some sex-specific results were observed in the current study. SA-born males (particularly WT males) exhibited reduced PPI, whereas SA-born female WT mice exhibited an anxiogenic profile in the EPM. These findings are consistent with other reports of sex-specific changes as a result of perinatal stress exposure, and how these differences might contribute to subsequent health outcomes of offspring79. One study showed greater prenatal maternal stressor sensitivity in male offspring for subsequent development of SZ spectrum disorders80. Studies have suggested that female fetuses are more flexible in adapting to adverse intrauterine conditions compared to male fetuses, but that this adaptability comes with a tradeoff of increased susceptibility to anxiety/depression81. This female-specific vulnerability to developing depression-like behavior has also been shown in response to early life stress exposure using the limited bedding model to induce fragmented maternal care82. Epidemiological studies have observed a winter/spring birth excess in people with depression1,83–85, and one study reported a higher excess in women (peak excess of 31% in women born in March compared to women in general population comparison group)86. Other studies report male vulnerability to this seasonality effect87, while some report no association between birth season and depression for either sex88. Studies to date have been limited, and more work is required to understand seasonality of birth effects on risk for affective disorder development. The sexually dimorphic results we observed fit within the existing prenatal stress vulnerability literature. Given the observation of limited sex-specific effects in the DAT HT mice – which were largely resilient to SA photoperiod birth effects – strengthen the implication that the sex-specific effects of such birth on WT mice fit into the literature. Future work should examine whether altered perinatal photoperiod exposure induces changes in maternal stress hormones (e.g. plasma corticosterone), which could be conferred to developing fetuses in a sex-specific manner.
Although we predicted that DAT-HT mice would be hypersensitive to SA-induced behavioral changes given their hypersensitivity in adulthood, they were resilient to photoperiod manipulation effects compared to their WT littermates. Investigations into the mechanisms underlying vulnerability (and, conversely, resiliency) to stress have recently become more numerous. Glucocorticoid administration during late gestation influences dopaminergic neural circuits, inducing an increased ratio of apoptotic to proliferative cells in the ventral tegmental area and subsequent reduction in dopaminergic input to the nucleus accumbens89. While the effects of early life stress on dopaminergic circuitry are complex (reviewed here90), the DAT mutation may protect against SA-induced behavioral changes by somehow counteracting photoperiod effects on developing dopaminergic pathways. The mechanism(s) underlying the observed resilience in DAT-HT mice remains unknown, however, and future work will determine how resilience is conferred.
In summary, SA perinatal photoperiod induces psychiatry-relevant behavioral profiles later in adulthood in mice, with vulnerability observed in WT mice. It is recognized that this photoperiod effect was consistent throughout but abrupt in its change, unlike changing light exposure in humans. Future studies will determine the mechanism(s) by which SA photoperiod exposure influences brain development to predispose toward emergence of psychiatry-relevant behaviors, as well as attempt to recreate gradual change effects on adult offspring. First, identifying the window of SA photoperiod exposure necessary to induce these behavioral effects will be critical to narrowing in on potential mechanisms (gestation vs. early life vs. a combination of the two time periods). If SA photoperiod exposure during gestation only is capable of inducing behavioral changes in offspring, stress-related changes in placental structure/gene expression might be contributing mechanisms. The placenta plays an active role in fetal brain development91, and maternal environment perturbations (e.g. hormone levels, nutritional state) are transmitted to the fetus via changes in placental function92. In adult rodents, SA photoperiod exposure results in elevated plasma corticosterone14, and exposure to elevated levels of maternal corticosterone affects placental growth and gene expression93. These gene expression changes may alter the transplacental signals received by the developing fetus, and by extension, the developing brain. Furthermore, maternal signals are capable of affecting long-term gene expression changes in offspring via induction of epigenetic mechanisms94. If behavioral changes occur after SA exposure during early life (post-gestational), it may point toward other mechanisms. Retinal projections reach the suprachiasmatic nucleus (central clock of the circadian system) shortly after birth95. Perinatal photoperiod-induced changes in retinal function96 and circadian rhythms4 have been previously reported, and may contribute to observed behavioral changes in offspring by influencing physiological crosstalk with the stress system95, thereby altering stress responses in adulthood. Many other potential mechanisms exist, and likely it is a combination of pre- and postnatal influences converging to produce SA-induced behavioral profiles. The interaction between environmental factors and developing neural circuitry is a critical part of the etiology of many psychiatric disorders; a better understanding of these complex processes will allow for the development of more effective therapeutics.
Acknowledgements
We would like to thank Drs. Mark A. Geyer, Susan Powell, Mana Parast, Jessica Deslauriers, and Arpi Minassian as well as Ms. Mahalah R. Buell and Mr. Richard F. Sharp for their support and advice throughout this work. This work was supported by R01-MH0104344 and R01-DA043535.
Author contributions
M.K., Z.C., D.D., and J.Y. designed studies included in the manuscript. M.K., Z.C., M.L., C.v.d.C., and J.W.Y. conducted experiments. M.K., Z.C., and J.Y. managed literature searches for study design and manuscript preparation. M.K., Z.C., C.v.d.C., and J.Y. undertook statistical analyses. M.K. wrote the first draft of the manuscript with contributions from Z.C. and J.Y. All authors approved the final manuscript.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Molly A. Kwiatkowski and Zackary A. Cope.
References
- 1.Disanto G, et al. Seasonal Distribution of Psychiatric Births in England. PLoS One. 2012;7:e34866. doi: 10.1371/journal.pone.0034866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Torrey EF, Rawlings RR, Ennis JM, Merrill DD, Flores DS. Birth seasonality in bipolar disorder, schizophrenia, schizoaffective disorder and stillbirths. Schizophr. Res. 1996;21:141–9. doi: 10.1016/0920-9964(96)00022-9. [DOI] [PubMed] [Google Scholar]
- 3.Cope ZA, Powell SB, Young JW. Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity. Genes, Brain Behav. 2016;15:27–44. doi: 10.1111/gbb.12268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ciarleglio, C. M., Axley, J. C., Strauss, B. R., Gamble, K. L. & McMahon, D. G. Perinatal photoperiod imprints the circadian clock. Nat. Publ. Gr. 14 (2011). [DOI] [PMC free article] [PubMed]
- 5.Green NH, Jackson CR, Iwamoto H, Tackenberg MC, McMahon DG. Photoperiod programs dorsal raphe serotonergic neurons and affective behaviors. Curr. Biol. 2015;25:1389–94. doi: 10.1016/j.cub.2015.03.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Young JW, Markou A. Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in Schizophrenia. Schizophr. Bull. 2015;41:1024–34. doi: 10.1093/schbul/sbv093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Young, J. W., Minassian, A. & Geyer, M. A. Locomotor profiling from rodents to the clinic and back again. in Current Topics in Behavioral Neurosciences28, 287–303 (Springer Verlag, 2016). [DOI] [PubMed]
- 8.Young JW, Geyer MA. Developing treatments for cognitive deficits in schizophrenia: the challenge of translation. J. Psychopharmacol. 2015;29:178–96. doi: 10.1177/0269881114555252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Young JW, Jentsch JD, Bussey TJ, Wallace TL, Hutcheson DM. Consideration of species differences in developing novel molecules as cognition enhancers. Neuroscience and Biobehavioral Reviews. 2013;37:2181–2193. doi: 10.1016/j.neubiorev.2012.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gilmour G, et al. Measuring the construct of executive control in schizophrenia: Defining and validating translational animal paradigms for discovery research. Neuroscience and Biobehavioral Reviews. 2013;37:2125–2140. doi: 10.1016/j.neubiorev.2012.04.006. [DOI] [PubMed] [Google Scholar]
- 11.Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacology and Therapeutics. 2009;122:150–202. doi: 10.1016/j.pharmthera.2009.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Phillips AG, Geyer MA, Robbins TW. Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders. Biological Psychiatry. 2018;83:915–923. doi: 10.1016/j.biopsych.2018.01.014. [DOI] [PubMed] [Google Scholar]
- 13.Robbins TW. Cross-species studies of cognition relevant to drug discovery: a translational approach. British Journal of Pharmacology. 2017;174:3191–3199. doi: 10.1111/bph.13826. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Dulcis D, Jamshidi P, Leutgeb S, Spitzer NC. Neurotransmitter Switching in the Adult Brain Regulates Behavior. Science (80-.). 2013;340:449–453. doi: 10.1126/science.1234152. [DOI] [PubMed] [Google Scholar]
- 15.Young, J. W. et al. Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder. Neuropsychopharmacology, 10.1038/s41386-018-0031-y (2018). [DOI] [PMC free article] [PubMed]
- 16.Halldorsdottir T, Binder EB. Gene × Environment Interactions: From Molecular Mechanisms to Behavior. Annu. Rev. Psychol. 2017;68:215–241. doi: 10.1146/annurev-psych-010416-044053. [DOI] [PubMed] [Google Scholar]
- 17.Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a Complex Trait: Evidence from a Meta-analysis of Twin Studies. Arch. Gen. Psychiatry. 2003;60:1187–1192. doi: 10.1001/archpsyc.60.12.1187. [DOI] [PubMed] [Google Scholar]
- 18.Brookes KJ, et al. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch. Gen. Psychiatry. 2006;63:74–81. doi: 10.1001/archpsyc.63.1.74. [DOI] [PubMed] [Google Scholar]
- 19.Esposito G, Azhari A, Borelli JL. Gene × environment interaction in developmental disorders: Where do we stand and what’s next? Front. Psychol. 2018;9:2036. doi: 10.3389/fpsyg.2018.02036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Geoffroy, P. A., Etain, B. & Houenou, J. Gene X Environment Interactions in Schizophrenia and Bipolar Disorder: Evidence from Neuroimaging. Front. Psychiatry4 (2013). [DOI] [PMC free article] [PubMed]
- 21.Hawi Z, et al. ADHD and DAT1: Further evidence of paternal over-transmission of risk alleles and haplotype. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2010;153:97–102. doi: 10.1002/ajmg.b.30960. [DOI] [PubMed] [Google Scholar]
- 22.Franke B, et al. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology. 2010;35:656–664. doi: 10.1038/npp.2009.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Huang CC, et al. Dopamine transporter gene may be associated with bipolar disorder and its personality traits. Eur. Arch. Psychiatry Clin. Neurosci. 2015;265:281–290. doi: 10.1007/s00406-014-0570-0. [DOI] [PubMed] [Google Scholar]
- 24.Huang CC, Lu RB, Shih MC, Yen CH, Huang SY. The dopamine transporter gene possibly affects personality traits in patients with early-onset major depressive disorder. Acta Neuropsychiatr. 2013;25:227–234. doi: 10.1111/acn.12019. [DOI] [PubMed] [Google Scholar]
- 25.Greenwood TA, et al. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophr. Res. 2016;170:30–40. doi: 10.1016/j.schres.2015.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Huang SY, et al. Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese. Schizophr. Res. 2010;116:68–74. doi: 10.1016/j.schres.2009.10.004. [DOI] [PubMed] [Google Scholar]
- 27.Zheng C, Shen Y, Xu Q. Association of intron 1 variants of the dopamine transporter gene with schizophrenia. Neurosci. Lett. 2012;513:137–140. doi: 10.1016/j.neulet.2012.02.015. [DOI] [PubMed] [Google Scholar]
- 28.Kennedy JL, et al. Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean Cohorts. Schizophr. Bull. 2016;42:772–81. doi: 10.1093/schbul/sbv191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Bidwell LC, et al. A family based association study of DRD4, DAT1, and 5HTT and continuous traits of attention-deficit hyperactivity disorder. Behav. Genet. 2011;41:165–174. doi: 10.1007/s10519-010-9437-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.De Azeredo LA, et al. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: Findings from a sample of adults. Eur. Arch. Psychiatry Clin. Neurosci. 2014;264:401–408. doi: 10.1007/s00406-014-0486-8. [DOI] [PubMed] [Google Scholar]
- 31.Gomez-Sanchez, C. I. et al. Attention deficit hyperactivity disorder: Genetic association study in a cohort of Spanish children. Behav. Brain Funct. 12 (2016). [DOI] [PMC free article] [PubMed]
- 32.Akutagava-Martins GC, et al. COMT and DAT1 genes are associated with hyperactivity and inattention traits in the 1993 pelotas birth cohort: Evidence of sex-specific combined effect. J. Psychiatry Neurosci. 2016;41:405–412. doi: 10.1503/jpn.150270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Gadow KD, Pinsonneault JK, Perlman G, Sadee W. Association of dopamine gene variants, emotion dysregulation and ADHD in autism spectrum disorder. Res. Dev. Disabil. 2014;35:1658–1665. doi: 10.1016/j.ridd.2014.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Cartier E, et al. Rare Autism-Associated Variants Implicate Syntaxin 1 (STX1 R26Q) Phosphorylation and the Dopamine Transporter (hDAT R51W) in Dopamine Neurotransmission and Behaviors. EBioMedicine. 2015;2:135–146. doi: 10.1016/j.ebiom.2015.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Pinsonneault JK, et al. Dopamine Transporter Gene Variant Affecting Expression in Human Brain is Associated with Bipolar Disorder. Neuropsychopharmacology. 2011;36:1644–1655. doi: 10.1038/npp.2011.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Greenwood TA, et al. Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2013;162:137–145. doi: 10.1002/ajmg.b.32108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Greenwood TA, Schork NJ, Eskin E, Kelsoe JR. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol. Psychiatry. 2006;11(125–33):115. doi: 10.1038/sj.mp.4001764. [DOI] [PubMed] [Google Scholar]
- 38.Greenwood TA, et al. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am. J. Med. Genet. 2001;105:145–51. doi: 10.1002/1096-8628(2001)9999:9999<::aid-ajmg1161>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- 39.Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum. Genet. 2009;126:51–90. doi: 10.1007/s00439-009-0694-x. [DOI] [PubMed] [Google Scholar]
- 40.Rao JS, Kellom M, Reese EA, Rapoport SI, Kim H-W. Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J. Affect. Disord. 2012;136:63–71. doi: 10.1016/j.jad.2011.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 41.Talkowski ME, et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum. Mol. Genet. 2008;17:747–58. doi: 10.1093/hmg/ddm347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Bamne MN, Talkowski ME, Chowdari KV, Nimgaonkar VL. Functional Analysis of Upstream Common Polymorphisms of the Dopamine Transporter Gene. Schizophr. Bull. 2010;36:977–982. doi: 10.1093/schbul/sbp005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Cosgrove VE, et al. Association between 5HTT, DAT1, and DRD4 and bipolar disorder in youth. Psychiatric Genetics. 2012;22:304. doi: 10.1097/YPG.0b013e3283539517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Huang CC, Lu RB, Shih MC, Yen CH, Huang SY. Association study of the dopamine transporter gene with personality traits and major depressive disorder in the Han Chinese population. Pharmacogenet. Genomics. 2011;21:94–97. doi: 10.1097/FPC.0b013e3283424d94. [DOI] [PubMed] [Google Scholar]
- 45.Bonvicini C, Faraone SV, Scassellati C. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies. Molecular Psychiatry. 2016;21:872–884. doi: 10.1038/mp.2016.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Yang B, et al. No association of SLC6A3 and SLC6A4 gene polymorphisms with schizophrenia in the Han Chinese population. Neurosci. Lett. 2014;579:114–118. doi: 10.1016/j.neulet.2014.07.004. [DOI] [PubMed] [Google Scholar]
- 47.Zhuang X, et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl. Acad. Sci. 2001;98:1982–1987. doi: 10.1073/pnas.98.4.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Young JW, Dulcis D. Investigating the mechanism(s) underlying switching between states in bipolar disorder. Eur. J. Pharmacol. 2015;759:151–62. doi: 10.1016/j.ejphar.2015.03.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 2013;106–107:1–16. doi: 10.1016/j.pneurobio.2013.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Geyer MA, Russo PV, Masten VL. Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol. Biochem. Behav. 1986;25:277–88. doi: 10.1016/0091-3057(86)90266-2. [DOI] [PubMed] [Google Scholar]
- 51.Perry W, et al. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch. Gen. Psychiatry. 2009;66:1072–80. doi: 10.1001/archgenpsychiatry.2009.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Risbrough VB, et al. Differential Contributions of Dopamine D1, D2, and D3 Receptors to MDMA-Induced Effects on Locomotor Behavior Patterns in Mice. Neuropsychopharmacology. 2006;31:2349–2358. doi: 10.1038/sj.npp.1301161. [DOI] [PubMed] [Google Scholar]
- 53.Young JW, et al. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacol. Biochem. Behav. 2010;96:7–15. doi: 10.1016/j.pbb.2010.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Young JW, Minassian A, Paulus MP, Geyer MA, Perry W. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci. Biobehav. Rev. 2007;31:882–96. doi: 10.1016/j.neubiorev.2007.05.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Can, A. et al. The mouse forced swim test. J. Vis. Exp. e3638, 10.3791/3638 (2012). [DOI] [PMC free article] [PubMed]
- 56.Young JW, Geyer MA. Action of modafinil–increased motivation via the dopamine transporter inhibition and D1 receptors? Biol. Psychiatry. 2010;67:784–7. doi: 10.1016/j.biopsych.2009.12.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Milienne-Petiot M, et al. The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania. Neuropharmacology. 2017;113:260–270. doi: 10.1016/j.neuropharm.2016.07.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry. 1992;49:206–15. doi: 10.1001/archpsyc.1992.01820030038005. [DOI] [PubMed] [Google Scholar]
- 59.Swerdlow NR, et al. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophr. Res. 2014;152:503–512. doi: 10.1016/j.schres.2013.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Hoenig K, Hochrein A, Quednow BB, Maier W, Wagner M. Impaired Prepulse Inhibition of Acoustic Startle in Obsessive-Compulsive Disorder. Biol. Psychiatry. 2005;57:1153–1158. doi: 10.1016/j.biopsych.2005.01.040. [DOI] [PubMed] [Google Scholar]
- 61.Ahmari SE, Risbrough VB, Geyer MA, Simpson HB. Impaired Sensorimotor Gating in Unmedicated Adults with Obsessive–Compulsive Disorder. Neuropsychopharmacology. 2012;37:1216–1223. doi: 10.1038/npp.2011.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Cheng C-H, Chan P-YS, Hsu S-C, Liu C-Y. Meta-analysis of sensorimotor gating in patients with autism spectrum disorders. Psychiatry Res. 2018;262:413–419. doi: 10.1016/j.psychres.2017.09.016. [DOI] [PubMed] [Google Scholar]
- 63.Gunaydin LA, Kreitzer AC. Cortico–Basal Ganglia Circuit Function in Psychiatric Disease. Annu. Rev. Physiol. 2016;78:327–350. doi: 10.1146/annurev-physiol-021115-105355. [DOI] [PubMed] [Google Scholar]
- 64.Nelson JC, Charney DS. The symptoms of major depressive illness. Am. J. Psychiatry. 1981;138:1–13. doi: 10.1176/ajp.138.1.1. [DOI] [PubMed] [Google Scholar]
- 65.Der-Avakian A, Barnes SA, Markou A, Pizzagalli DA. Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders. Curr. Top. Behav. Neurosci. 2016;28:231–62. doi: 10.1007/7854_2015_5004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Dichter GS, Smoski MJ, Kampov-Polevoy AB, Gallop R, Garbutt JC. Unipolar depression does not moderate responses to the sweet taste test. Depress. Anxiety. 2010;27:859–863. doi: 10.1002/da.20690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Aguayo, G. A., Vaillant, M. T., Arendt, C., Bachim, S. & Pull, C. B. Taste preference and psychopathology. Bull. Soc. Sci. Med. Grand. Duche. Luxemb. 7–14 (2012). [PubMed]
- 68.Berlin I, Givry-Steiner L, Lecrubier Y, Puech AJ. Measures of anhedonia and hedonic responses to sucrose in depressive and schizophrenic patients in comparison with healthy subjects. Eur. Psychiatry. 1998;13:303–309. doi: 10.1016/S0924-9338(98)80048-5. [DOI] [PubMed] [Google Scholar]
- 69.Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 2005;4:775–790. doi: 10.1038/nrd1825. [DOI] [PubMed] [Google Scholar]
- 70.Doron R, et al. A novel herbal treatment reduces depressive-like behaviors and increases BDNF levels in the brain of stressed mice. Life Sci. 2014;94:151–157. doi: 10.1016/j.lfs.2013.10.025. [DOI] [PubMed] [Google Scholar]
- 71.de Kloet ER, Molendijk ML. Coping with the Forced Swim Stressor: Towards Understanding an Adaptive Mechanism. Neural Plast. 2016;2016:6503162. doi: 10.1155/2016/6503162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Anyan J, Amir S. Too Depressed to Swim or Too Afraid to Stop? A Reinterpretation of the Forced Swim Test as a Measure of Anxiety-Like Behavior. Neuropsychopharmacology. 2018;43:931–933. doi: 10.1038/npp.2017.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Andreatini R, Bacellar LFS. The relationship between anxiety and depression in animal models: A study using the forced swimming test and elevated plus-maze. Brazilian J. Med. Biol. Res. 1999;32:1121–1126. doi: 10.1590/s0100-879x1999000900011. [DOI] [PubMed] [Google Scholar]
- 74.Fervaha G, et al. Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making. J. Psychiatr. Res. 2013;47:1590–1596. doi: 10.1016/j.jpsychires.2013.08.003. [DOI] [PubMed] [Google Scholar]
- 75.Gold JM, et al. Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol. Psychiatry. 2013;74:130–6. doi: 10.1016/j.biopsych.2012.12.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Waltz JA, Gold JM. Probabilistic reversal learning impairments in schizophrenia: Further evidence of orbitofrontal dysfunction. Schizophr. Res. 2007;93:296–303. doi: 10.1016/j.schres.2007.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Hershenberg R, et al. Diminished effort on a progressive ratio task in both unipolar and bipolar depression. J. Affect. Disord. 2016;196:97–100. doi: 10.1016/j.jad.2016.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Reddy LF, Waltz JA, Green MF, Wynn JK, Horan WP. Probabilistic Reversal Learning in Schizophrenia: Stability of Deficits and Potential Causal Mechanisms. Schizophr. Bull. 2016;42:942–951. doi: 10.1093/schbul/sbv226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Sutherland S, Brunwasser SM. Sex Differences in Vulnerability to Prenatal Stress: a Review of the Recent Literature. Curr. Psychiatry Rep. 2018;20:102. doi: 10.1007/s11920-018-0961-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Fineberg AM, et al. Fetal exposure to maternal stress and risk for schizophrenia spectrum disorders among offspring: Differential influences of fetal sex. Psychiatry Res. 2016;236:91–97. doi: 10.1016/j.psychres.2015.12.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Sandman CA, Glynn LM, Davis EP. Is there a viability–vulnerability tradeoff? Sex differences in fetal programming. J. Psychosom. Res. 2013;75:327–335. doi: 10.1016/j.jpsychores.2013.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Goodwill, H. L. et al. Early life stress leads to sex differences in development of depressive-like outcomes in a mouse model. Neuropsychopharmacology, 10.1038/s41386-018-0195-5 (2018). [DOI] [PMC free article] [PubMed]
- 83.Joiner TE, Pfaff JJ, Acres JG, Johnson F. Birth month and suicidal and depressive symptoms in Australians born in the Southern vs. the Northern hemisphere. Psychiatry Res. 2002;112:89–92. doi: 10.1016/s0165-1781(02)00183-x. [DOI] [PubMed] [Google Scholar]
- 84.Clarke M, et al. Seasonality of births in affective disorder in an Irish population. Eur. Psychiatry. 1998;13:353–358. doi: 10.1016/S0924-9338(99)80702-0. [DOI] [PubMed] [Google Scholar]
- 85.Brochard A, et al. [Endogenous affective disorder, seasons of birth and photoperiodicity] Encephale. 1994;20:459–472. [PubMed] [Google Scholar]
- 86.Mino Y, Oshima I, Okagami K. Seasonality of birth in patients with mood disorders in Japan. J. Affect. Disord. 2000;59:41–46. doi: 10.1016/s0165-0327(99)00130-5. [DOI] [PubMed] [Google Scholar]
- 87.Quesada JA, Nolasco A. Relación entre el mes de nacimiento y la prevalencia de enfermedades crónicas. Med. Clin. (Barc). 2017;148:489–494. doi: 10.1016/j.medcli.2016.10.035. [DOI] [PubMed] [Google Scholar]
- 88.Pérez-Rincón, H. Seasonal predominance in the date of birth in schizophrenia and affective disease. Gac. Med. Mex. 127, 7–11, discussion 11-2 (1991). [PubMed]
- 89.Leão P, et al. Programming effects of antenatal dexamethasone in the developing mesolimbic pathways. Synapse. 2007;61:40–49. doi: 10.1002/syn.20341. [DOI] [PubMed] [Google Scholar]
- 90.Rodrigues A-J, Leão P, Carvalho M, Almeida OFX, Sousa N. Potential programming of dopaminergic circuits by early life stress. Psychopharmacology (Berl). 2011;214:107–20. doi: 10.1007/s00213-010-2085-3. [DOI] [PubMed] [Google Scholar]
- 91.Zeltser LM, Leibel RL. Roles of the placenta in fetal brain development. Proc. Natl. Acad. Sci. USA. 2011;108:15667–8. doi: 10.1073/pnas.1112239108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Jansson T, Powell TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin. Sci. 2007;113:1–13. doi: 10.1042/CS20060339. [DOI] [PubMed] [Google Scholar]
- 93.Cuffe JSM, O’Sullivan L, Simmons DG, Anderson ST, Moritz KM. Maternal Corticosterone Exposure in the Mouse Has Sex-Specific Effects on Placental Growth and mRNA Expression. Endocrinology. 2012;153:5500–5511. doi: 10.1210/en.2012-1479. [DOI] [PubMed] [Google Scholar]
- 94.Seckl JR. Prenatal glucocorticoids and long-term programming. Eur. J. Endocrinol. 2004;151(Suppl 3):U49–62. doi: 10.1530/eje.0.151u049. [DOI] [PubMed] [Google Scholar]
- 95.Astiz M, Oster H. Perinatal Programming of Circadian Clock-Stress Crosstalk. Neural Plast. 2018;2018:1–12. doi: 10.1155/2018/5689165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Jackson CR, Capozzi M, Dai H, McMahon DG. Circadian Perinatal Photoperiod Has Enduring Effects on Retinal Dopamine and Visual Function. J. Neurosci. 2014;34:4627–4633. doi: 10.1523/JNEUROSCI.4887-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Henry BL, et al. Inhibitory deficits in euthymic bipolar disorder patients assessed in the human behavioral pattern monitor. J. Affect. Disord. 2013;150:948–954. doi: 10.1016/j.jad.2013.05.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Minassian A, et al. Repeated Assessment of Exploration and Novelty Seeking in the Human Behavioral Pattern Monitor in Bipolar Disorder Patients and Healthy Individuals. PLoS One. 2011;6:e24185. doi: 10.1371/journal.pone.0024185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl). 1987;92:180–5. doi: 10.1007/BF00177912. [DOI] [PubMed] [Google Scholar]
- 100.Bourin M. Animal models for screening anxiolytic-like drugs: a perspective. Dialogues Clin. Neurosci. 2015;17:295–303. doi: 10.31887/DCNS.2015.17.3/mbourin. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Wolf DH, et al. Amotivation in Schizophrenia: Integrated Assessment With Behavioral, Clinical, and Imaging Measures. Schizophr. Bull. 2014;40:1328–1337. doi: 10.1093/schbul/sbu026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Treadway MT, Bossaller NA, Shelton RC, Zald DH. Effort-based decision-making in major depressive disorder: A translational model of motivational anhedonia. J. Abnorm. Psychol. 2012;121:553–558. doi: 10.1037/a0028813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Tezcan D, Tumkaya S, Bora E. Reversal learning in patients with obsessive-compulsive disorder (OCD) and their unaffected relatives: Is orbitofrontal dysfunction an endophenotype of OCD? Psychiatry Res. 2017;252:231–233. doi: 10.1016/j.psychres.2017.03.001. [DOI] [PubMed] [Google Scholar]